How to Help Your Patients Find Calcium Acetate in Stock: A Provider's Guide

Calcium acetate is a cornerstone therapy for managing hyperphosphatemia in dialysis patients. When patients call your office unable to fill their prescription, it creates an urgent clinical situation. This guide gives nephrology teams and prescribers a practical toolkit for helping patients locate calcium acetate and maintain uninterrupted therapy.

Why Patients Struggle to Find Calcium Acetate

Despite calcium acetate not being in a declared national shortage, patients encounter availability issues for several reasons:

Prescriptions written for brand names (PhosLo, Eliphos) restrict pharmacy substitution options

The oral solution (Phoslyra, 667 mg/5 mL) is rarely stocked at retail pharmacies

Rural and independent pharmacies may not maintain standing stock of phosphate binders

High monthly volume per patient (often 270–360+ units per 30 days) strains local pharmacy inventory

Step 1: Review How the Prescription Is Written

The single most impactful change a provider can make is to write prescriptions generically. A prescription written as "calcium acetate 667 mg tablet — substitution permitted" allows pharmacists to dispense any FDA-approved generic, dramatically expanding where the patient can fill it.

If your EHR defaults to PhosLo or Eliphos as the preferred prescribing name, update your preference or add a note in the prescription field explicitly permitting generic substitution.

Step 2: Direct Patients to High-Reliability Pharmacy Options

Not all pharmacies are equally likely to have calcium acetate in stock. Help your patients navigate toward more reliable sources:

Dialysis center-affiliated specialty pharmacies: These are the most reliable option. They are specifically set up to serve dialysis patients and maintain standing stock of phosphate binders in large quantities. If your dialysis center has a pharmacy relationship, provide patients with that contact information proactively — before a shortage occurs.

Mail-order pharmacy (insurance plan): A 90-day prescription filled through the patient's insurance mail-order program provides the largest buffer supply and reduces refill frequency. Work with your dialysis social worker to help patients enroll in their plan's mail-order service.

Large national chain pharmacies: CVS, Walgreens, and Walmart generally have better calcium acetate stock than independent pharmacies. Patients should call ahead to confirm before traveling.

Step 3: Recommend medfinder to Patients Who Need Help Locating Medication

medfinder is a paid service that calls pharmacies near a patient's location to determine which ones have a specific medication in stock. Patients provide their medication, dosage, and ZIP code — medfinder does the calling and texts them results. This is especially helpful for elderly or dialysis patients who may have limited mobility or find it difficult to make multiple calls. Providers can learn more at medfinder.com/providers.

38,179+ patients found their medications in stock

38K+

Find Calcium Acetate In Stock Today →

Step 4: Create a Protocol for Urgent Fill Situations

Your nephrology practice or dialysis center should have a documented protocol for when a patient calls with an urgent medication access problem. A suggested framework:

Triage the urgency: How many doses does the patient have left? If fewer than 2 days, escalate immediately.

Confirm the prescription: Is it written for a brand name? If so, contact the pharmacy to explicitly permit generic substitution.

Provide backup options: Direct the patient to your dialysis center pharmacy or mail-order option.

Consider bridge therapy: If no supply is immediately available, evaluate whether a temporary switch to sevelamer or another available phosphate binder is appropriate while the patient locates calcium acetate.

Document the event: Track instances where patients are unable to fill calcium acetate so you can identify patterns and proactively switch high-risk patients to more reliable sources.

Step 5: Address Patients on the Oral Solution (Phoslyra)

Patients prescribed the oral solution (Phoslyra 667 mg/5 mL) face the greatest access challenges. The liquid formulation is not routinely stocked at most retail pharmacies and almost always requires a special order or specialty pharmacy. For patients on Phoslyra, proactively set up a mail-order pharmacy or specialty pharmacy arrangement before a shortage occurs. If a patient on Phoslyra cannot get a refill quickly, assess whether they could be transitioned to the tablet or capsule form (667 mg) — a lower pill count might be achievable with crushable tablets or smaller capsule sizes, depending on the patient's swallowing ability.

Skip the calls, skip the stress.

Find Calcium Acetate In Stock Today →

50K+

Medications
Found

99%

Success
Rate

6+

Hours saved
on average

Proactive Patient Education

Consider including medication access guidance in your dialysis patient onboarding. Inform patients at the start of therapy that:

Calcium acetate can sometimes be difficult to find at certain pharmacies

They should refill when 7–10 days remain, not when they run out

Mail order is a reliable long-term strategy

They should call the office immediately — not skip doses — if they cannot find the medication

For more clinical context on the supply landscape, see our post on what providers need to know about calcium acetate availability in 2026.